SOURCE: Rheologics Technologies, Inc.

February 20, 2007 07:30 ET

Rheologics President & COO Daniel Cho to Be Interviewed by Meet The CEO™

Question Submission Available

EXTON, PA -- (MARKET WIRE) -- February 20, 2007 -- Rheologics Technologies, Inc. (PINKSHEETS: RTGI) ("Rheologics"), the leader in the study of blood viscosity and its relationship to cardiovascular disease, announced today that Company President and Chief Operating Officer Mr. Daniel Cho will be interviewed by Meet The CEO™ ('MTC') Friday, February 23rd. Mr. Cho will discuss the Rheolog®, the Company's new blood flow diagnostic technology, important trends in cardiovascular medicine, and the relevance of the Rheolog® in acute and preventive cardiology.

Shareholders and members of the media and brokerage community wishing to submit questions for consideration by Mr. Cho may do so in either of the following manners:

1) Call MTC's affiliate studio partner On Air, at (888) 88ONAIR (888-886-6247), ext. 28 and record your question when prompted. If chosen, your question will be audio-patched directly into the interview, or

2) Submit an email question, with reference to Rheologics, to info@meettheceo.com.

Questions need to be submitted via telephone or email no later than 6pm ET Thursday, February 22nd to be considered.

The interview will be posted as a streaming MP3 and Podcast download, and written transcript, on www.meettheceo.com 9am ET Monday, February 26th, 2006.

About Rheologics Technologies, Inc.

Rheologics is committed to developing and commercializing innovative medical technologies that improve the diagnosis and treatment of human disease. The Company is accomplishing its mission by monitoring an overlooked basic physiological parameter -- whole blood viscosity. Rheologics believes that its innovations will ultimately enable the preventative diagnosis of diseases and the development of new cost-effective therapies that conquer today's most difficult medical problems, thereby improving the quality of life for millions of people worldwide. Further information on Rheologics may be found at www.rheologics.com.

About Meet The CEO™

Meet The CEO™ provides a forum for domestic and international public and private companies, industry analysts and financial professionals to inform the business/investment community of their corporate models/areas of expertise, quarterly updates and fundamental milestones. The MTC environment affords executives and other specialized industry authorities a unique and innovative platform to articulate their insights, goals and opinions beyond the standard Wall Street pitch.

For further information, visit www.meettheceo.com or call 888.CEO.8899.

Cautionary Note Regarding Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including but not limited to statements regarding the Company's beliefs and expectations about the performance and benefits of its technology; marketing and commercialization activities; and our beliefs regarding research and development efforts. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ. All forward-looking statements herein are based on information available to us as of the date hereof, and we undertake no obligation to update forward-looking statements to reflect events or circumstances occurring after this date.

Contact Information